What is Idexx Laboratories's revenue?

Idexx Laboratories (IDXX) generated $4.4B in revenue over the trailing twelve months, up 13.1% year over year.

Is Idexx Laboratories profitable?

Idexx Laboratories reported $1.1B in net income over the trailing twelve months, a 24.6% net margin.

What are Idexx Laboratories's profit margins?

Gross margin is 62.1% and operating margin is 31.6%, with a 24.6% net margin.

What is Idexx Laboratories's earnings per share?

Idexx Laboratories's diluted EPS over the trailing twelve months is $13.59.

Where does Idexx Laboratories's income statement data come from?

Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Idexx Laboratories IDXX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$1.14B+4.6%	$1.09B-1.3%	$1.11B-0.4%	$1.11B+11.1%	$998.43M+4.6%
Total cost of revenue	$418.08M-3.3%	$432.47M+2.5%	$421.89M+1.7%	$414.73M+10.6%	$375.05M-2.2%
Gross profit	$722.74M+9.8%	$658.11M-3.7%	$683.35M-1.6%	$694.73M+11.4%	$623.38M+9.2%
Gross margin	63.4%+3.0pp	60.3%-1.5pp	61.8%-0.8pp	62.6%+0.2pp	62.4%+2.6pp
Research and development	$65.79M-1.6%	$66.83M+5.4%	$63.42M+2.5%	$61.9M+4.8%	$59.06M+2.3%
Selling and marketing	$175.25M+4.9%	$167.06M+5.0%	$159.16M-1.2%	$161.11M+3.1%	$156.22M+4.1%
General and administrative	$119.12M+9.7%	$108.62M+2.5%	$105.94M+7.4%	$98.68M+7.8%	$91.56M-9.5%
Total operating expenses	$360.15M+5.2%	$342.51M+4.3%	$328.51M+2.1%	$321.69M+4.8%	$306.85M-0.7%
Operating income	$362.59M+14.9%	$315.61M-11.1%	$354.85M-4.9%	$373.05M+17.9%	$316.53M+21.0%
Operating margin	31.8%+2.8pp	28.9%-3.2pp	32.1%-1.5pp	33.6%+1.9pp	31.7%+4.3pp
Interest expense	$7.74M-16.0%	$9.21M-13.6%	$10.66M-5.9%	$11.32M+47.7%	$7.67M+2.2%
Income before income taxes	$355.44M+15.8%	$306.98M-11.0%	$344.77M-4.9%	$362.35M+16.9%	$310.08M+20.9%
Income tax expense	$77M+31.0%	$58.79M-16.2%	$70.16M+2.6%	$68.36M+1.4%	$67.41M+67.5%
Net income	$278.45M+12.2%	$248.19M-9.6%	$274.61M-6.6%	$293.99M+21.1%	$242.68M+12.3%
Net margin	24.4%+1.7pp	22.8%-2.1pp	24.8%-1.7pp	26.5%+2.2pp	24.3%+1.7pp
Diluted earnings per share	$3.47+12.3%	$3.09-9.1%	$3.40-6.3%	$3.63+22.6%	$2.96+13.0%
EBITDA	$400.27M+13.0%	$354.33M-9.5%	$391.47M-4.2%	$408.82M+16.6%	$350.6M+18.7%
EBITDA margin	35.1%+2.6pp	32.5%-2.9pp	35.4%-1.4pp	36.8%+1.7pp	35.1%+4.2pp
EBIT	$362.59M+14.9%	$315.61M-11.1%	$354.85M-4.9%	$373.05M+17.9%	$316.53M+21.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Idexx Laboratories.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Idexx Laboratories's revenue?: Idexx Laboratories (IDXX) generated $4.4B in revenue over the trailing twelve months, up 13.1% year over year.
Is Idexx Laboratories profitable?: Idexx Laboratories reported $1.1B in net income over the trailing twelve months, a 24.6% net margin.
What are Idexx Laboratories's profit margins?: Gross margin is 62.1% and operating margin is 31.6%, with a 24.6% net margin.
What is Idexx Laboratories's earnings per share?: Idexx Laboratories's diluted EPS over the trailing twelve months is $13.59.
Where does Idexx Laboratories's income statement data come from?: Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.